Indeed, attempts to inhibit TGF-β signalling have yielded mixed results in murine models of arthritis with some studies showing amelioration of disease and others exacerbation (Sakuma et al, 2007; Aarts et al, 2022). This evidence concerns the gene TGFB1 and arthritic joint disease.